Lnc2Cancer

Experimentally Supported Human LncRNA and Cancer Associations Database

LncRNA centric

Cancer centric

Advanced search

Drug resistant

Circulating

Prognosis

Detail


   LncRNA Name MIR100HG
   Synonyms MIR100HG, AGD1, linc-NeD125, lncRNA-N2
   Region GRCh38_11:122028327-122556721    Sequence
   Ensembl ENSG00000255248
   RefSeq NR_024430
   Circulating
   Drug-resisitant
   Prognostic
   MiRNA
   Variant
   TF
   Methylation
   Cancer Name pancreatic ductal adenocarcinoma
   ICD-0-3 C25.3  M8500/3
   Methods RNA-seq, qPCR, Western blot etc.
   Sample cell lines (BxPC-3, PANC-1 and COLO357)
   Expression Pattern up-regulated
   Function Description

although the pro-tumourigenic miR-100 and miR-125b accordingly increase,the amount of anti-tumourigenic let-7a is unchanged, as TGF-B also induces LIN28B inhibiting its maturation.Notably, we demonstrate that inactivation of miR-125b or miR-100 affects the TGF-B-mediated response indicating that these miRNAs are important TGF-B effectors.We integrate AGO2-RIP-seq with RNA-seq to identify the global regulation exerted by these miRNAs in PDAC cells.Transcripts targeted by miR-125b and miR-100 significantly overlap and mainly inhibit p53 and cell-cell junctions'pathways.Together, we uncover that TGF-B induces an lncRNA, whose encoded miRNAs, miR-100, let-7a and miR-125b play opposing roles in controlling PDAC tumourigenesis.

   Pubmed ID 29748571
   Year 2018
   Title TGF-B induces miR-100 and miR-125b but blocks let-7a through LIN28B controlling PDAC progression.
   External Links
   Links for  MIR100HG GenBank       HGNC       lncrnadb       Noncode
   Links for  pancreatic ductal adenocarcinoma Omim       Cosmic

CopyRight © College of Bioinformatics Science and Technology, Harbin Medical University, China.